Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17643583 | 0.89 | POLB (0.34) | POLBHTTSMN1; SMN2GAAMAPT | |
| SCHEMBL18059283 | 0.89 | POLB (0.33) | POLBGAAMAPTHPGDRAB9A | |
| SCHEMBL17518762 | 0.84 | ATM (0.33) | — | |
| SCHEMBL17541750 | 0.81 | MAPT (0.33) | SMN1; SMN2MAPTHPGDRAB9A | |
| SCHEMBL16603298 | 0.79 | MTNR1A (0.31) | — | |
| SCHEMBL16627767 | 0.79 | MEN1 (0.38) | POLBHTTSMN1; SMN2GAAMAPT | |
| SCHEMBL17518763 | 0.76 | ATM (0.35) | SMN1; SMN2MAPTHPGDRAB9A | |
| SCHEMBL18376077 | 0.75 | CES1 (0.35) | HTTSMN1; SMN2MAPTHPGDRAB9A | |
| SCHEMBL16603162 | 0.72 | MAPT (0.35) | HTTSMN1; SMN2MAPTHPGDRAB9A | |
| SCHEMBL16603267 | 0.72 | MAOA (0.35) | HTTSMN1; SMN2HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170012223-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170012223-A1 | Organic Electroluminescent Materials and Devices | EML4, MT-ND4L, MT-ND4 | POLB 1211/4885HTT 1519/4885SMN1; SMN2 4000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.